カテゴリ： MarketLine, ロシア, 企業調査

OJSC IC Allianz ：企業の戦略・SWOT・財務情報

◆英語タイトル：OJSC IC Allianz - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C11614
◆発行会社（調査会社）：MarketLine
◆発行日：2018年11月
◆ページ数：19
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：ロシア
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

OJSC IC Allianz – Strategy, SWOT and Corporate Finance Report
Summary

OJSC IC Allianz – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

OJSC IC Allianz (IC Allianz) a subsidiary of Allianz New Europe Holding GmbH, a division of Allianz SE, is an insurance company. The company offers a range of life and non-life insurance products to both individuals and business customers. The company’s offerings include property insurance, travel insurance, obligatory motor third party liability insurance, civil liability insurance, health insurance, voluntary medical insurance, corporate life insurance, pension insurance, agriculture insurance, annuities, employees insurance, motor own damage insurance, cargo insurance, and liability insurance. IC Allianz has reinsurance contracts with Swiss Re, Hannover Re, and Allianz SE. It distributes its products through a network of branch offices. IC Allianz is headquartered in Moscow, Russia.

The company reported gross premiums written of RUB5,550.3 million in FY2016, representing an annual decrease of 15.6% over FY2015. It reported net premiums earned of RUB3,648.2 million in FY2016, representing a decline of 53.9% over FY2015.

Scope

- Detailed information on OJSC IC Allianz required for business and competitor intelligence needs
- A study of the major internal and external factors affecting OJSC IC Allianz in the form of a SWOT analysis
- An in-depth view of the business model of OJSC IC Allianz including a breakdown and examination of key business segments
- Intelligence on OJSC IC Allianz ‘s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about OJSC IC Allianz , such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of OJSC IC Allianz and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess OJSC IC Allianz as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on OJSC IC Allianz ‘s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
OJSC IC Allianz : Company Overview 6
OJSC IC Allianz : Overview and Key Facts 6
OJSC IC Allianz : Overview 6
OJSC IC Allianz : Key Facts 6
OJSC IC Allianz : Key Employees 7
OJSC IC Allianz : Major Products and Services 8
OJSC IC Allianz : Company History 9
OJSC IC Allianz : Locations and Subsidiaries 12
OJSC IC Allianz : Key Competitors 13
OJSC IC Allianz : Company Analysis 14
OJSC IC Allianz : Business Description 14
OJSC IC Allianz : SWOT Analysis 15
OJSC IC Allianz : SWOT Overview 15
OJSC IC Allianz : Strengths 15
OJSC IC Allianz : Weaknesses 15
OJSC IC Allianz : Opportunities 16
OJSC IC Allianz : Threats 16
Appendix 17
Contact Us 17
Methodology 17
About MarketLine 18

List of Tables
Table 1: OJSC IC Allianz : Key Facts
Table 2: OJSC IC Allianz : Key Employees
Table 3: OJSC IC Allianz : Company History
Table 4: OJSC IC Allianz : Locations and Subsidiaries
Table 5: OJSC IC Allianz : Key Competitors



★海外企業調査レポート[OJSC IC Allianz ：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Tel Aviv Sourasky Medical Center：製薬・医療：M&Aディール及び事業提携情報
    Summary Tel Aviv Sourasky Medical Center (Sourasky Medical) is an academic medical center that provides patient-centered care, research and education services. The center offers services in the areas of cardiology, dermatology, gastroenterology, general surgery, genetics, emergency medicine, rheumat …
  • Biogen Inc (BIIB)-製薬・医療分野：企業M&A・提携分析
    Summary Biogen Inc (Biogen) is a global biotechnology company that manufactures and markets drugs for the treatment of neurodegenerative diseases and rare and autoimmune disorders. Its marketed products include Avonex (interferon beta-1a), Tysabri (natalizumab), Tecfidera (dimethyl fumarate), Zinbry …
  • Tessa Therapeutics Pte Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary Tessa Therapeutics Pte Ltd (Tessa Therapeutics) is a clinical-stage biotechnology company that discovers, develops, and commercializes cancer immunotherapies that redirect the body’s powerful anti-viral immune response and identify and exterminate cancer cells. The company provides products …
  • Constellation Pharmaceuticals Inc (CNST)：企業の財務・戦略的SWOT分析
    Constellation Pharmaceuticals Inc (CNST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Arafura Resources Ltd：企業の戦略・SWOT・財務分析
    Arafura Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Arafura Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • FUJIFILM Holdings Corporation：企業の戦略・SWOT・財務情報
    FUJIFILM Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary FUJIFILM Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • SmarTone Telecommunications Holdings Ltd (315)：企業の財務・戦略的SWOT分析
    SmarTone Telecommunications Holdings Ltd (315) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Croatia Airlines dd：戦略・SWOT・企業財務分析
    Croatia Airlines dd - Strategy, SWOT and Corporate Finance Report Summary Croatia Airlines dd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Biosceptre International Ltd：製薬・医療：M&Aディール及び事業提携情報
    Summary Biosceptre International Ltd (Biosceptre) is a biotechnology company that develops antibody technologies for applications in the diagnosis and treatment of cancer. The company develops imaging technologies to detect and monitor cancer. Its diagnostic products are used for the detection of va …
  • Dilafor AB：製薬・医療：M&Aディール及び事業提携情報
    Summary Dilafor AB (Dilafor) is a drug development company that develops pharmaceutical products for obstetric indications. The company offers tafoxiparin, a proprietary heparan sulfate mimetic, which is used as an adjuvant therapy to promote cervical ripening and myometrial contractility. Its tafox …
  • T. Rowe Price Group, Inc.：企業のM&A・事業提携・投資動向
    T. Rowe Price Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's T. Rowe Price Group, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • G4S Plc (GFS)：企業の財務・戦略的SWOT分析
    G4S Plc (GFS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Tulip Diagnostics (P) Ltd：医療機器：M&Aディール及び事業提携情報
    Summary Tulip Diagnostics (P) Ltd (Tulip Diagnostics), a subsidiary of Tulip Group is a diagnostic company that manufactures and markets in vitro diagnostic reagents and kits. The company provides assay systems for immunohaematology, hematology, rheumatology, infectious diseases, hemostasis, and ins …
  • Pharmaxis Ltd (PXS)：企業の財務・戦略的SWOT分析
    Summary Pharmaxis Ltd (Pharmaxis) is a pharmaceutical research company that develops and commercialize healthcare products. The company provides products such as aridol which identify twitchy and assist in diagnosing and managing asthma, and bronchitol which restores normal lung hydration, improves …
  • Taiheiyo Cement Corporation (5233)：企業の財務・戦略的SWOT分析
    Taiheiyo Cement Corporation (5233) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • DIC Corporation：企業の戦略・SWOT・財務分析
    DIC Corporation - Strategy, SWOT and Corporate Finance Report Summary DIC Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • PT Garuda Indonesia (Persero) Tbk：企業の戦略・SWOT・財務分析
    PT Garuda Indonesia (Persero) Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Garuda Indonesia (Persero) Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • ICL Group Ltd (ICL)：企業の財務・戦略的SWOT分析
    ICL Group Ltd (ICL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • The Royal Bank of Scotland Group Plc：企業の戦略・SWOT・財務情報
    The Royal Bank of Scotland Group Plc - Strategy, SWOT and Corporate Finance Report Summary The Royal Bank of Scotland Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • The PNC Financial Services Group Inc：企業のM&A・事業提携・投資動向
    The PNC Financial Services Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The PNC Financial Services Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆